Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02654119
Title Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Nebraska
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.